SENSOR FOR INFRARED COMMUNICATION USING PLANT NANOBIONICS
    1.
    发明申请
    SENSOR FOR INFRARED COMMUNICATION USING PLANT NANOBIONICS 审中-公开
    用植物纳米传感器进行红外通信的传感器

    公开(公告)号:WO2017096317A1

    公开(公告)日:2017-06-08

    申请号:PCT/US2016/064847

    申请日:2016-12-02

    摘要: A living plant can function as self-powered auto-samplers and preconcentrators of an analyte within ambient groundwater, detectors of the analyte contained therein. For example, a pair of near infrared (IR) fluorescent sensors embedded within the mesophyll of the plant leaf can be used as detectors of the nitroaromatic molecules, with the first IR channel engineered through CoPhMoRe to recognize analyte via an IR fluorescent emission and the second IR channel including a functionalized nanostructure that acts as an invariant reference signal.

    摘要翻译: 有生命的植物可以用作环境地下水中分析物的自供电自动采样器和预浓缩器,其中包含的分析物的检测器。 例如,嵌入在植物叶的叶肉内的一对近红外(IR)荧光传感器可以用作硝基芳香族分子的检测器,其中通过CoPhMoRe工程化的第一IR通道经由IR荧光发射识别分析物,而第二 红外通道包括功能化的纳米结构,充当不变的参考信号。

    METHODS FOR DETECTING, DIAGNOSING AND TREATING ENDOMETRIAL CANCER
    2.
    发明申请
    METHODS FOR DETECTING, DIAGNOSING AND TREATING ENDOMETRIAL CANCER 审中-公开
    检测,诊断和治疗子宫内膜癌的方法

    公开(公告)号:WO2017003936A1

    公开(公告)日:2017-01-05

    申请号:PCT/US2016/039603

    申请日:2016-06-27

    发明人: BAHADO-SINGH, Ray

    摘要: The present invention relates to methods for detecting, diagnosing and/or treating endometrial cancer by detecting in a biological sample from a patient the levels of one or more of the metabolites: C14.2, PC ae C38:1, 3-Hydroxybutyric acid, C18:2, PC ae C40:1, and C6 (C4:1-DC). In some embodiments, the method also includes diagnosing the patient with endometrial cancer when the one or more metabolites in the biological sample is at a different level than a statistically validated threshold for the one or more metabolites, and ultrasound indicates endometrial cancer in the patient. In further embodiments, once endometrial cancer is diagnosed, the patient is treated for the endometrial cancer.

    摘要翻译: 本发明涉及通过在患者的生物样品中检测,诊断和/或治疗子宫内膜癌中的一种或多种代谢物的水平的方法:C14.2,PCae C38:1,3-羟基丁酸, C18:2,PCae C40:1和C6(C4:1-DC)。 在一些实施方案中,当生物样品中的一种或多种代谢物与一种或多种代谢物的统计学验证的阈值不同的水平时,所述方法还包括诊断患有子宫内膜癌的患者,超声表示患者的子宫内膜癌。 在另外的实施方案中,一旦诊断出子宫内膜癌,就对患者进行子宫内膜癌治疗。